InvestorsHub Logo
Followers 6
Posts 186
Boards Moderated 0
Alias Born 02/25/2011

Re: slcimmuno post# 97915

Wednesday, 04/15/2015 11:32:17 AM

Wednesday, April 15, 2015 11:32:17 AM

Post# of 403563
Thanks SLC. The ramifications of that Merck/NGM deal (pre-clinical!) are astounding.

FORBES
http://www.forbes.com/sites/greatspeculations/2015/03/03/mercks-partnership-with-ngm-is-a-bold-move/
EXCERPT: Last week Merck signed a deal with NGM Biopharmaceuticals, which we believe is a bold and a long-term move. Under the multi-year agreement, Merck will make a payment of $95 million to NGM to establish a co-development alliance and acquire another 15% equity stake for another $106 million. The company also offered $250 million of additional funding for any new drugs that the biopharma firm develops going forward. The deal gives a lot of flexibility and room for taking risk to NGM. It is a bold move considering there is only one disclosed compound in pre-clinical stage by NGM and it seems that Merck is essentially paying a premium to acquire its team of researchers and scientists.


Control your inner dialogue...talk and think positively all the time. Brian Tracy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News